Robert Mashal - 08 Jan 2024 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Reporting relationship: Director
Issuer ticker: NUVB
Reported as of: 08 Jan 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Jan 2024, 16:22:44 UTC
Next SEC filing: 10 Oct 2024
Source filing: View source filing
Reporting owner signature: /s/ Ron A. Metzger, Attorney-in-Fact

Key filing fact

Robert Mashal filed Form 4 for Nuvation Bio Inc. (NUVB) on 10 Jan 2024.

Key facts

This page summarizes Robert Mashal's Form 4 filing for Nuvation Bio Inc. (NUVB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 10 Jan 2024, 16:22.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NUVB transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +741,179
Change %
Price: $0.000000
Shares after: 741,179
Date: 08 Jan 2024
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 741,179
Exercise price: $1.55
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

1/36th of the total number of shares shall vest and become exercisable on each monthly anniversary of January 8, 2024, subject to Reporting Person's continuous service on each such vesting date.